25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Loss-of-function mutations in DJ-1 (PARK7) gene account for about 1% of all familial Parkinson's disease (PD). While its physiological function(s) are not completely clear, DJ-1 protects neurons against oxidative stress in both in vitro and in vivo models of PD. The molecular mechanism(s) through which DJ-1 alleviates oxidative stress-mediated damage remains elusive. In this study, we identified Paraoxonase-2 (PON2) as an interacting target of DJ-1. PON2 activity is elevated in response to oxidative stress and DJ-1 is crucial for this response. Importantly, we showed that PON2 deficiency hypersensitizes neurons to oxidative stress induced by MPP + (1-methyl-4-phenylpyridinium). Conversely, over-expression of PON2 protects neurons in this death paradigm. Interestingly, PON2 effectively rescues DJ-1 deficiency-mediated hypersensitivity to oxidative stress. Taken together, our data suggest a model by which DJ-1 exerts its antioxidant activities, at least partly through regulation of PON2.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: not found

          A simplified system for generating recombinant adenoviruses.

          Recombinant adenoviruses provide a versatile system for gene expression studies and therapeutic applications. We report herein a strategy that simplifies the generation and production of such viruses. A recombinant adenoviral plasmid is generated with a minimum of enzymatic manipulations, using homologous recombination in bacteria rather than in eukaryotic cells. After transfections of such plasmids into a mammalian packaging cell line, viral production is conveniently followed with the aid of green fluorescent protein, encoded by a gene incorporated into the viral backbone. Homogeneous viruses can be obtained from this procedure without plaque purification. This system should expedite the process of generating and testing recombinant adenoviruses for a variety of purposes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Large-scale mapping of human protein–protein interactions by mass spectrometry

            Mapping protein–protein interactions is an invaluable tool for understanding protein function. Here, we report the first large-scale study of protein–protein interactions in human cells using a mass spectrometry-based approach. The study maps protein interactions for 338 bait proteins that were selected based on known or suspected disease and functional associations. Large-scale immunoprecipitation of Flag-tagged versions of these proteins followed by LC-ESI-MS/MS analysis resulted in the identification of 24 540 potential protein interactions. False positives and redundant hits were filtered out using empirical criteria and a calculated interaction confidence score, producing a data set of 6463 interactions between 2235 distinct proteins. This data set was further cross-validated using previously published and predicted human protein interactions. In-depth mining of the data set shows that it represents a valuable source of novel protein–protein interactions with relevance to human diseases. In addition, via our preliminary analysis, we report many novel protein interactions and pathway associations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

              In idiopathic Parkinson's disease massive cell death occurs in the dopamine-containing substantia nigra. A link between the vulnerability of nigral neurons and the prominent pigmentation of the substantia nigra, though long suspected, has not been proved. This possibility is supported by evidence that N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite MPP+, the latter of which causes destruction of nigral neurons, bind to neuromelanin. We have directly tested this hypothesis by a quantitative analysis of neuromelanin-pigmented neurons in control and parkinsonian midbrains. The findings demonstrate first that the dopamine-containing cell groups of the normal human midbrain differ markedly from each other in the percentage of neuromelanin-pigmented neurons they contain. Second, the estimated cell loss in these cell groups in Parkinson's disease is directly correlated (r = 0.97, P = 0.0057) with the percentage of neuromelanin-pigmented neurons normally present in them. Third, within each cell group in the Parkinson's brains, there is greater relative sparing of non-pigmented than of neuromelanin-pigmented neurons. This evidence suggests a selective vulnerability of the neuromelanin-pigmented subpopulation of dopamine-containing mesencephalic neurons in Parkinson's disease.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2014
                11 September 2014
                : 9
                : 9
                : e106601
                Affiliations
                [1 ]Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
                [2 ]Department of Medicine and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at Univeristy of California Los Angeles, Los Angeles, California, United States of America
                [3 ]Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America
                [4 ]Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada
                [5 ]The Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada
                [6 ]Ottawa Institute of Systems Biology (OISB), University of Ottawa, Ottawa, Ontario, Canada
                [7 ]Department of Cogno-Mechatronics Engineering, Pusan National University, Busan, Korea
                [8 ]Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
                University of S. Florida College of Medicine, United States of America
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                Conceived and designed the experiments: MP NB DSP STR. Performed the experiments: MP NB YZ MWCR DQ HA II EH. Analyzed the data: MP NB MWCR DQ. Contributed reagents/materials/analysis tools: NB TWM RHK DF STR SC DCV RSS. Wrote the paper: MP YZ HA DQ MWCR DSP.

                Article
                PONE-D-14-06291
                10.1371/journal.pone.0106601
                4161380
                25210784
                0b4e7d8f-724c-44ad-bc10-127596f00ac6
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 11 March 2014
                : 5 August 2014
                Page count
                Pages: 10
                Funding
                This work was supported by grants from Parkinson's Society Canada (PSC); Ontario Graduate Scholarships in Science and Technology (OGSST); the Canadian Institutes of Health Research (CIHR); National Heart, Lung, and Blood Institute (NHLBI) [1RO1HL71776 to S.T.R]; Heart and Stroke Foundation of Ontario (HSFO); Neuroscience Canada (Brain Repair Grant); Parkinson's Disease Foundation (PDF); The Michael J. Fox foundation for Parkinson’s research (MJFOX); the Centre for Stroke Recovery (CSR) and World Class University program (WCU) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea [R31-2008-000-20004-0 to D.S.P]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and Life Sciences
                Biochemistry
                Neurochemistry
                Neuroscience
                Cellular Neuroscience
                Molecular Neuroscience
                Medicine and Health Sciences
                Neurology
                Neurobiology of Disease and Regeneration

                Uncategorized
                Uncategorized

                Comments

                Comment on this article